Doshi Dipal sold TRDA

March 3, 2026 · Form 4 insider transaction

Doshi Dipal sold 19,181 shares of Entrada Therapeutics, Inc. at $11.76 per share, a transaction worth $225.5K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Disposed (sell-side)
Shares
19,181
Price
$11.76
Total value
$225.5K
RoleDirector
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateMarch 3, 2026
Filing dateMarch 3, 2026
Shares owned after526,014
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations. The sale does not represent a discretionary trade by the reporting person.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.22 to $12.095, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

View the original Form 4 on SEC EDGAR